Company Profile

Lynx Dx Inc
Profile last edited on: 9/21/22      CAGE: 8EWM7      UEI: CVMDCVXNU3K1

Business Identifier: Prostate cancer diagnostic from urine samples
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

333 Jackson Plaza | Suite 60
Ann Arbor, MI 48103
   (734) 212-6561
Location: Single
Congr. District: 12
County: Washtenaw

Public Profile

Lynx Dx Inc is biotechnology startup out of University of Michigan using prostate cancer diagnostic assay to measure levels of cancer specific genes in the urine. During this period of national crisis, the firm shifted its focus to large-scale COVID-19 testing.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 2 NIH $1,999,642
Project Title: Urine Diagnostic Tool for the Detection of High-Grade Prostate Cancer

Key People / Management

  Arul Chinnaiyan

  Matt Martin

  Yashar Sharufi Niknafs

Company News

There are no news available.